BIT

6.67%

3.2¢ biotron limited

Ann: Letter to Shareholders, page-381

First 381 Last

Share
Profile

Follow
Thaliat

4,912 Posts.

833

16/11/23

18:35

Post #: 70947733
Share

Originally posted by FreshInvester: ↑

So what should she have said instead of coming weeks?
-Expect within the coming months (few months).
-By the end of the year possibly early into next year at the latest though unlikely.
-Between the date of ..... At the earliest and this date.....at the latest based on our calculations and time constraints.

We can't write it for her or biotron because we don't have the date and staff capability to calculate a good estimation of when the headline data is likely to release. I said it a month ago, when it comes to deadlines language is very important, timing is important. You have had many years to figure how to write a press release and not give false expectations, you have a very good PR representative and lawyer to check over your release to make sure what you have said won't set up false expectations or waver confidence with your words. You set up clear releases that build the SP confidence, until you have the data ready to release and create a solid value that reflects your product. Then the next time you say we are in discussions with a partner or have finished stage 3 trials in the future people have the belief to know you have a clear timeline and your words have meaning. I bought in at 3 cents based off of the science and nice trials, I am still holding but one thing that gets me upset with a company and a great product is their business management ability, do they hit targets is right up there for me, because you can have the best product in the world but if you are not marketing and communicating effectively and not going full steam ahead than that product isn't worth a dollar.

Expand

Fingers X is our current marketing manager, he's all over it sending up to 1000 emails a night to all the gurus of the world LOL

BIT Price at posting: 9.0¢ Sentiment: Buy Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

TRP

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

HXL

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

BGL

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

MM1

Geochemical work at Newington picks up gold and copper anomalies for Midas

PEC

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

AAI

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

OPL

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

There are more pages in this discussion • 1 more message in this thread...

First 381 Last

Add BIT (ASX) to my watchlist

(20min delay)
Last 3.2¢		Change 0.002(6.67%)		Mkt cap ! $28.87M

Open	High	Low	Value	Volume
3.1¢	3.3¢	3.1¢	$13.79K	424.2K

Buyers (Bids)

No.	Vol.	Price($)
1	329429	3.2¢

Sellers (Offers)

Price($)	Vol.	No.
3.4¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	329429	0.032
3	81516	0.031
9	375471	0.030
3	1008888	0.029
4	468000	0.028

Price($)	Vol.	No.
0.034	100000	1
0.035	436199	5
0.037	537816	2
0.038	162500	1
0.039	317353	2

Last trade - 15.51pm 26/07/2024 (20 minute delay)

BIT (ASX) Chart

Ann: Letter to Shareholders, page-381

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Letter to Shareholders, page-381

Top Stories

Tissue Repairs soars nearly 32% on TGA approval for wound healing gel

Hexima shares rise 66% on proposed acquisition of AI player Real Thing Entertainment

Bellevue aims for 45% production increase by FY 2028, announces $150M placement

Geochemical work at Newington picks up gold and copper anomalies for Midas

Perpetual sniffs TREOs beyond 4000ppm at Raptor play in Brazil

NYSE-listed Alcoa Corp joins ASX through key JV acquisition

Quarterly & half yearly reports: Drives Newmont up, Ampol flat, while Fortescue plunges 2.6%

Acquisitions roundup: European Lithium, Diatreme Resources and SRJ Technologies

Opyl forms JV with UK and US consortium to bring products to the world

Capital raisings wrap: Brainchip, Ovanti, Lake and VHM

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News